<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2004-03-29" modified="2024-01-24" version="92" xmlns="http://uniprot.org/uniprot">
  <accession>Q9X2V7</accession>
  <name>MCJA_ECOLX</name>
  <protein>
    <recommendedName>
      <fullName evidence="12">Microcin J25</fullName>
      <shortName evidence="12">MccJ25</shortName>
    </recommendedName>
    <alternativeName>
      <fullName evidence="13">Class II lasso peptide</fullName>
    </alternativeName>
    <alternativeName>
      <fullName evidence="13">Ribosomally synthesized and post-translationally modified peptide</fullName>
      <shortName evidence="13">RiPP</shortName>
    </alternativeName>
  </protein>
  <gene>
    <name type="primary">mcjA</name>
  </gene>
  <organism>
    <name type="scientific">Escherichia coli</name>
    <dbReference type="NCBI Taxonomy" id="562"/>
    <lineage>
      <taxon>Bacteria</taxon>
      <taxon>Pseudomonadota</taxon>
      <taxon>Gammaproteobacteria</taxon>
      <taxon>Enterobacterales</taxon>
      <taxon>Enterobacteriaceae</taxon>
      <taxon>Escherichia</taxon>
    </lineage>
  </organism>
  <geneLocation type="plasmid">
    <name>pTUC100</name>
  </geneLocation>
  <reference key="1">
    <citation type="journal article" date="1999" name="J. Bacteriol." volume="181" first="2659" last="2662">
      <title>Sequence analysis of the four plasmid genes required to produce the circular peptide antibiotic microcin J25.</title>
      <authorList>
        <person name="Solbiati J.O."/>
        <person name="Ciaccio M."/>
        <person name="Farias R.N."/>
        <person name="Gonzalez-Pastor J.E."/>
        <person name="Moreno F."/>
        <person name="Salomon R.A."/>
      </authorList>
      <dbReference type="PubMed" id="10198038"/>
      <dbReference type="DOI" id="10.1128/jb.181.8.2659-2662.1999"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
    <source>
      <strain>AY25</strain>
    </source>
  </reference>
  <reference key="2">
    <citation type="journal article" date="1999" name="Eur. J. Biochem." volume="259" first="747" last="755">
      <title>The cyclic structure of microcin J25, a 21-residue peptide antibiotic from Escherichia coli.</title>
      <authorList>
        <person name="Blond A."/>
        <person name="Peduzzi J."/>
        <person name="Goulard C."/>
        <person name="Chiuchiolo M.J."/>
        <person name="Barthelemy M."/>
        <person name="Prigent Y."/>
        <person name="Salomon R.A."/>
        <person name="Farias R.N."/>
        <person name="Moreno F."/>
        <person name="Rebuffat S."/>
      </authorList>
      <dbReference type="PubMed" id="10092860"/>
      <dbReference type="DOI" id="10.1046/j.1432-1327.1999.00085.x"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 38-58</scope>
    <scope>MASS SPECTROMETRY</scope>
  </reference>
  <reference key="3">
    <citation type="journal article" date="1992" name="J. Bacteriol." volume="174" first="7428" last="7435">
      <title>Microcin 25, a novel antimicrobial peptide produced by Escherichia coli.</title>
      <authorList>
        <person name="Salomon R.A."/>
        <person name="Farias R.N."/>
      </authorList>
      <dbReference type="PubMed" id="1429464"/>
      <dbReference type="DOI" id="10.1128/jb.174.22.7428-7435.1992"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="4">
    <citation type="journal article" date="2001" name="FEMS Microbiol. Lett." volume="204" first="265" last="270">
      <title>The antibacterial action of microcin J25: evidence for disruption of cytoplasmic membrane energization in Salmonella newport.</title>
      <authorList>
        <person name="Rintoul M.R."/>
        <person name="de Arcuri B.F."/>
        <person name="Salomon R.A."/>
        <person name="Farias R.N."/>
        <person name="Morero R.D."/>
      </authorList>
      <dbReference type="PubMed" id="11731133"/>
      <dbReference type="DOI" id="10.1111/j.1574-6968.2001.tb10895.x"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="5">
    <citation type="journal article" date="2001" name="J. Bacteriol." volume="183" first="4543" last="4550">
      <title>Escherichia coli RNA polymerase is the target of the cyclopeptide antibiotic microcin J25.</title>
      <authorList>
        <person name="Delgado M.A."/>
        <person name="Rintoul M.R."/>
        <person name="Farias R.N."/>
        <person name="Salomon R.A."/>
      </authorList>
      <dbReference type="PubMed" id="11443089"/>
      <dbReference type="DOI" id="10.1128/jb.183.15.4543-4550.2001"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="6">
    <citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="50867" last="50875">
      <title>Mutations of bacterial RNA polymerase leading to resistance to microcin J25.</title>
      <authorList>
        <person name="Yuzenkova J."/>
        <person name="Delgado M.A."/>
        <person name="Nechaev S."/>
        <person name="Savalia D."/>
        <person name="Epshtein V."/>
        <person name="Artsimovitch I."/>
        <person name="Mooney R.A."/>
        <person name="Landick R."/>
        <person name="Farias R.N."/>
        <person name="Salomon R.A."/>
        <person name="Severinov K."/>
      </authorList>
      <dbReference type="PubMed" id="12401787"/>
      <dbReference type="DOI" id="10.1074/jbc.m209425200"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="7">
    <citation type="journal article" date="2004" name="Mol. Cell" volume="14" first="739" last="751">
      <title>Antibacterial peptide microcin J25 inhibits transcription by binding within and obstructing the RNA polymerase secondary channel.</title>
      <authorList>
        <person name="Mukhopadhyay J."/>
        <person name="Sineva E."/>
        <person name="Knight J."/>
        <person name="Levy R.M."/>
        <person name="Ebright R.H."/>
      </authorList>
      <dbReference type="PubMed" id="15200952"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2004.06.010"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="8">
    <citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="25589" last="25595">
      <title>Systematic structure-activity analysis of microcin J25.</title>
      <authorList>
        <person name="Pavlova O."/>
        <person name="Mukhopadhyay J."/>
        <person name="Sineva E."/>
        <person name="Ebright R.H."/>
        <person name="Severinov K."/>
      </authorList>
      <dbReference type="PubMed" id="18632663"/>
      <dbReference type="DOI" id="10.1074/jbc.m803995200"/>
    </citation>
    <scope>MUTAGENESIS OF GLY-41; PRO-44; TYR-46; PHE-47; ILE-50; THR-52; PHE-56 AND TYR-57</scope>
  </reference>
  <reference key="9">
    <citation type="journal article" date="2003" name="J. Am. Chem. Soc." volume="125" first="12382" last="12383">
      <title>Structure of antibacterial peptide microcin J25: a 21-residue lariat protoknot.</title>
      <authorList>
        <person name="Bayro M.J."/>
        <person name="Mukhopadhyay J."/>
        <person name="Swapna G.V.T."/>
        <person name="Huang J.Y."/>
        <person name="Ma L.-C."/>
        <person name="Sineva E."/>
        <person name="Dawson P.E."/>
        <person name="Montelione G.T."/>
        <person name="Ebright R.H."/>
      </authorList>
      <dbReference type="PubMed" id="14531661"/>
      <dbReference type="DOI" id="10.1021/ja036677e"/>
    </citation>
    <scope>STRUCTURE BY NMR OF 38-58</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
  </reference>
  <reference key="10">
    <citation type="journal article" date="2003" name="J. Am. Chem. Soc." volume="125" first="12464" last="12474">
      <title>Microcin J25 has a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone.</title>
      <authorList>
        <person name="Rosengren K.J."/>
        <person name="Clark R.J."/>
        <person name="Daly N.L."/>
        <person name="Goeransson U."/>
        <person name="Jones A."/>
        <person name="Craik D.J."/>
      </authorList>
      <dbReference type="PubMed" id="14531690"/>
      <dbReference type="DOI" id="10.1021/ja0367703"/>
    </citation>
    <scope>STRUCTURE BY NMR OF 38-58</scope>
    <scope>CHARACTERIZATION</scope>
    <scope>MASS SPECTROMETRY</scope>
  </reference>
  <reference key="11">
    <citation type="journal article" date="2003" name="J. Am. Chem. Soc." volume="125" first="12475" last="12483">
      <title>Structure of microcin J25, a peptide inhibitor of bacterial RNA polymerase, is a lassoed tail.</title>
      <authorList>
        <person name="Wilson K.-A."/>
        <person name="Kalkum M."/>
        <person name="Ottesen J."/>
        <person name="Yuzenkova J."/>
        <person name="Chait B.T."/>
        <person name="Landick R."/>
        <person name="Muir T."/>
        <person name="Severinov K."/>
        <person name="Darst S.A."/>
      </authorList>
      <dbReference type="PubMed" id="14531691"/>
      <dbReference type="DOI" id="10.1021/ja036756q"/>
    </citation>
    <scope>STRUCTURE BY NMR OF 38-58</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
  </reference>
  <reference key="12">
    <citation type="journal article" date="2019" name="Proc. Natl. Acad. Sci. U.S.A." volume="116" first="1273" last="1278">
      <title>Structural mechanism of transcription inhibition by lasso peptides microcin J25 and capistruin.</title>
      <authorList>
        <person name="Braffman N.R."/>
        <person name="Piscotta F.J."/>
        <person name="Hauver J."/>
        <person name="Campbell E.A."/>
        <person name="Link A.J."/>
        <person name="Darst S.A."/>
      </authorList>
      <dbReference type="PubMed" id="30626643"/>
      <dbReference type="DOI" id="10.1073/pnas.1817352116"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (3.68 ANGSTROMS) OF 38-58 IN COMPLEX WITH E.COLI RNA POLYMERASE</scope>
    <scope>FUNCTION</scope>
  </reference>
  <comment type="function">
    <text evidence="2 3 4 5 9 11">Peptide antibiotic that functions through inhibition of the bacterial DNA-dependent RNA polymerase (RNAP) (PubMed:11443089, PubMed:12401787). Inhibits transcription by binding deep within RNAP secondary channel, where it sterically blocks the folding of the trigger loop, which is essential for efficient catalysis (PubMed:15200952, PubMed:30626643). In addition, it also seems to restrict access of nucleotide substrates to the catalytic center, and shows a partially competitive mode of inhibition with them (PubMed:15200952, PubMed:30626643). Exhibits potent bacteriocidal activity against a range of Enterobacteriaceae, including several pathogenic E.coli, Salmonella and Shigella strains (PubMed:1429464). Also acts on the cytoplasmic membrane of Salmonella newport, producing alteration of membrane permeability and disruption of the subsequent gradient dissipation, which inhibits several processes essential for cell viability, such as oxygen consumption (PubMed:11731133). Induces bacterial filamentation in susceptible cells in a non-SOS-dependent way, but this phenotype may result from impaired transcription of genes coding for cell division proteins (PubMed:1429464).</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-16100378">
      <id>Q9X2V7</id>
    </interactant>
    <interactant intactId="EBI-1116714">
      <id>P06971</id>
      <label>fhuA</label>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location evidence="15">Secreted</location>
    </subcellularLocation>
  </comment>
  <comment type="induction">
    <text evidence="5">At the onset of stationary growth phase.</text>
  </comment>
  <comment type="mass spectrometry" mass="2107.0" method="Electrospray" evidence="1"/>
  <comment type="mass spectrometry" mass="2106.0" method="MALDI" evidence="7"/>
  <comment type="caution">
    <text evidence="14">Was originally thought to have a head-to-tail cyclic structure, but actually has a threaded side chain-to-backbone ring structure that is penetrated by the C-terminal tail in a noose-like motif.</text>
  </comment>
  <comment type="online information" name="Protein Spotlight">
    <link uri="https://web.expasy.org/spotlight/back_issues/072"/>
    <text>Entanglement - Issue 72 of July 2006</text>
  </comment>
  <dbReference type="EMBL" id="AF061787">
    <property type="protein sequence ID" value="AAD28494.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="RefSeq" id="WP_001513516.1">
    <property type="nucleotide sequence ID" value="NZ_WVVR01000053.1"/>
  </dbReference>
  <dbReference type="RefSeq" id="YP_009071192.1">
    <property type="nucleotide sequence ID" value="NC_025179.1"/>
  </dbReference>
  <dbReference type="PDB" id="1PP5">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=38-58"/>
  </dbReference>
  <dbReference type="PDB" id="1Q71">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=38-58"/>
  </dbReference>
  <dbReference type="PDB" id="1S7P">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=38-47, B=48-58"/>
  </dbReference>
  <dbReference type="PDB" id="2MMT">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=38-58"/>
  </dbReference>
  <dbReference type="PDB" id="2MMW">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=38-58"/>
  </dbReference>
  <dbReference type="PDB" id="4CU4">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.30 A"/>
    <property type="chains" value="B=38-58"/>
  </dbReference>
  <dbReference type="PDB" id="6N60">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.68 A"/>
    <property type="chains" value="M=38-58"/>
  </dbReference>
  <dbReference type="PDBsum" id="1PP5"/>
  <dbReference type="PDBsum" id="1Q71"/>
  <dbReference type="PDBsum" id="1S7P"/>
  <dbReference type="PDBsum" id="2MMT"/>
  <dbReference type="PDBsum" id="2MMW"/>
  <dbReference type="PDBsum" id="4CU4"/>
  <dbReference type="PDBsum" id="6N60"/>
  <dbReference type="AlphaFoldDB" id="Q9X2V7"/>
  <dbReference type="BMRB" id="Q9X2V7"/>
  <dbReference type="PCDDB" id="Q9X2V7"/>
  <dbReference type="SMR" id="Q9X2V7"/>
  <dbReference type="DIP" id="DIP-60856N"/>
  <dbReference type="IntAct" id="Q9X2V7">
    <property type="interactions" value="1"/>
  </dbReference>
  <dbReference type="TCDB" id="9.A.52.1.1">
    <property type="family name" value="the microcin j25 (microsin j25) family"/>
  </dbReference>
  <dbReference type="GeneID" id="83575962"/>
  <dbReference type="EvolutionaryTrace" id="Q9X2V7"/>
  <dbReference type="GO" id="GO:0005576">
    <property type="term" value="C:extracellular region"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-SubCell"/>
  </dbReference>
  <dbReference type="GO" id="GO:0042742">
    <property type="term" value="P:defense response to bacterium"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0031640">
    <property type="term" value="P:killing of cells of another organism"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="NCBIfam" id="NF033471">
    <property type="entry name" value="J25_fam_lasso"/>
    <property type="match status" value="1"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0044">Antibiotic</keyword>
  <keyword id="KW-0929">Antimicrobial</keyword>
  <keyword id="KW-0078">Bacteriocin</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-1017">Isopeptide bond</keyword>
  <keyword id="KW-0614">Plasmid</keyword>
  <keyword id="KW-0964">Secreted</keyword>
  <feature type="propeptide" id="PRO_0000002774" evidence="1">
    <location>
      <begin position="1"/>
      <end position="37"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000002775" description="Microcin J25" evidence="1">
    <location>
      <begin position="38"/>
      <end position="58"/>
    </location>
  </feature>
  <feature type="site" description="Essential for permeation into bacteria" evidence="10">
    <location>
      <position position="41"/>
    </location>
  </feature>
  <feature type="site" description="Essential for permeation into bacteria" evidence="10">
    <location>
      <position position="44"/>
    </location>
  </feature>
  <feature type="site" description="Essential for permeation into bacteria and for RNAP inhibition" evidence="10">
    <location>
      <position position="46"/>
    </location>
  </feature>
  <feature type="site" description="Essential for permeation into bacteria" evidence="10">
    <location>
      <position position="47"/>
    </location>
  </feature>
  <feature type="site" description="Essential for permeation into bacteria" evidence="10">
    <location>
      <position position="56"/>
    </location>
  </feature>
  <feature type="site" description="Essential for permeation into bacteria" evidence="10">
    <location>
      <position position="57"/>
    </location>
  </feature>
  <feature type="cross-link" description="Isoglutamyl glycine isopeptide (Gly-Glu)" evidence="6 7 8">
    <location>
      <begin position="38"/>
      <end position="45"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of RNAP inhibition and loss of bacterial growth inhibition." evidence="10">
    <original>G</original>
    <variation>A</variation>
    <variation>C</variation>
    <variation>D</variation>
    <variation>E</variation>
    <variation>F</variation>
    <variation>G</variation>
    <variation>H</variation>
    <variation>I</variation>
    <variation>K</variation>
    <variation>L</variation>
    <variation>M</variation>
    <variation>N</variation>
    <variation>P</variation>
    <variation>Q</variation>
    <variation>R</variation>
    <variation>T</variation>
    <variation>V</variation>
    <variation>W</variation>
    <variation>Y</variation>
    <location>
      <position position="41"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No change of RNAP inhibition but loss of bacterial growth inhibition." evidence="10">
    <original>G</original>
    <variation>S</variation>
    <location>
      <position position="41"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No change of RNAP inhibition but loss of bacterial growth inhibition." evidence="10">
    <original>P</original>
    <variation>A</variation>
    <variation>L</variation>
    <variation>V</variation>
    <location>
      <position position="44"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of RNAP inhibition and loss of bacterial growth inhibition." evidence="10">
    <original>P</original>
    <variation>C</variation>
    <variation>D</variation>
    <variation>E</variation>
    <variation>F</variation>
    <variation>G</variation>
    <variation>H</variation>
    <variation>I</variation>
    <variation>K</variation>
    <variation>M</variation>
    <variation>N</variation>
    <variation>P</variation>
    <variation>Q</variation>
    <variation>R</variation>
    <variation>S</variation>
    <variation>T</variation>
    <variation>W</variation>
    <variation>Y</variation>
    <location>
      <position position="44"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of RNAP inhibition." evidence="10">
    <original>Y</original>
    <variation>A</variation>
    <variation>C</variation>
    <variation>D</variation>
    <variation>E</variation>
    <variation>F</variation>
    <variation>G</variation>
    <variation>H</variation>
    <variation>I</variation>
    <variation>K</variation>
    <variation>L</variation>
    <variation>M</variation>
    <variation>N</variation>
    <variation>P</variation>
    <variation>Q</variation>
    <variation>R</variation>
    <variation>S</variation>
    <variation>T</variation>
    <variation>V</variation>
    <variation>W</variation>
    <variation>Y</variation>
    <location>
      <position position="46"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of RNAP inhibition and loss of bacterial growth inhibition." evidence="10">
    <original>F</original>
    <variation>A</variation>
    <variation>C</variation>
    <variation>D</variation>
    <variation>E</variation>
    <variation>F</variation>
    <variation>G</variation>
    <variation>H</variation>
    <variation>K</variation>
    <variation>L</variation>
    <variation>N</variation>
    <variation>P</variation>
    <variation>Q</variation>
    <variation>T</variation>
    <variation>V</variation>
    <variation>Y</variation>
    <location>
      <position position="47"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No change of RNAP inhibition but loss of bacterial growth inhibition." evidence="10">
    <original>F</original>
    <variation>I</variation>
    <variation>M</variation>
    <variation>R</variation>
    <variation>S</variation>
    <variation>W</variation>
    <location>
      <position position="47"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Increase in bacterial growth inhibition." evidence="10">
    <original>I</original>
    <variation>A</variation>
    <variation>L</variation>
    <variation>M</variation>
    <variation>N</variation>
    <variation>P</variation>
    <variation>R</variation>
    <variation>T</variation>
    <location>
      <position position="50"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Increase in bacterial growth inhibition." evidence="10">
    <original>T</original>
    <variation>A</variation>
    <variation>F</variation>
    <variation>H</variation>
    <variation>L</variation>
    <location>
      <position position="52"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No change of RNAP inhibition but increase in permeation into bacterial cells and bacterial growth inhibition." evidence="10">
    <original>T</original>
    <variation>G</variation>
    <location>
      <position position="52"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of RNAP inhibition and loss of bacterial growth inhibition." evidence="10">
    <original>F</original>
    <variation>A</variation>
    <variation>C</variation>
    <variation>D</variation>
    <variation>E</variation>
    <variation>F</variation>
    <variation>G</variation>
    <variation>H</variation>
    <variation>I</variation>
    <variation>K</variation>
    <variation>L</variation>
    <variation>M</variation>
    <variation>N</variation>
    <variation>P</variation>
    <variation>Q</variation>
    <variation>R</variation>
    <variation>S</variation>
    <variation>T</variation>
    <variation>V</variation>
    <location>
      <position position="56"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No change of RNAP inhibition but loss of bacterial growth inhibition." evidence="10">
    <original>F</original>
    <variation>W</variation>
    <variation>Y</variation>
    <location>
      <position position="56"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss RNAP inhibition, and loss of bacterial growth inhibition." evidence="10">
    <original>Y</original>
    <variation>A</variation>
    <variation>C</variation>
    <variation>D</variation>
    <variation>E</variation>
    <variation>F</variation>
    <variation>G</variation>
    <variation>H</variation>
    <variation>I</variation>
    <variation>K</variation>
    <variation>L</variation>
    <variation>M</variation>
    <variation>N</variation>
    <variation>P</variation>
    <variation>Q</variation>
    <variation>R</variation>
    <variation>S</variation>
    <variation>T</variation>
    <variation>V</variation>
    <variation>W</variation>
    <variation>Y</variation>
    <location>
      <position position="57"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No change of RNAP inhibition, and loss of bacterial growth inhibition." evidence="10">
    <original>Y</original>
    <variation>F</variation>
    <location>
      <position position="57"/>
    </location>
  </feature>
  <feature type="strand" evidence="17">
    <location>
      <begin position="39"/>
      <end position="44"/>
    </location>
  </feature>
  <feature type="strand" evidence="16">
    <location>
      <begin position="48"/>
      <end position="51"/>
    </location>
  </feature>
  <feature type="strand" evidence="16">
    <location>
      <begin position="55"/>
      <end position="57"/>
    </location>
  </feature>
  <evidence type="ECO:0000269" key="1">
    <source>
      <dbReference type="PubMed" id="10092860"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="2">
    <source>
      <dbReference type="PubMed" id="11443089"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="3">
    <source>
      <dbReference type="PubMed" id="11731133"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="4">
    <source>
      <dbReference type="PubMed" id="12401787"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="5">
    <source>
      <dbReference type="PubMed" id="1429464"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="14531661"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="14531690"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="14531691"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="15200952"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="18632663"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="30626643"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="12">
    <source>
      <dbReference type="PubMed" id="1429464"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="13">
    <source>
      <dbReference type="PubMed" id="30626643"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="14">
    <source>
      <dbReference type="PubMed" id="10092860"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="15">
    <source>
      <dbReference type="PubMed" id="18632663"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="16">
    <source>
      <dbReference type="PDB" id="1PP5"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="17">
    <source>
      <dbReference type="PDB" id="4CU4"/>
    </source>
  </evidence>
  <sequence length="58" mass="6200" checksum="A9F4393C8EAAC8FA" modified="1999-11-01" version="1" precursor="true">MIKHFHFNKLSSGKKNNVPSPAKGVIQIKKSASQLTKGGAGHVPEYFVGIGTPISFYG</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>